Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.8968
-0.0427 (-4.54%)
At close: Sep 8, 2026, 4:00 PM EDT
0.9080
+0.0112 (1.25%)
After-hours: Sep 8, 2026, 7:55 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $171.24 million as of September 8, 2026. Its market cap has increased by 22.67% in one year.
Market Cap
171.24M
Enterprise Value
161.68M
1-Year Change
22.67%
Ranking
Category
Stock Price
$0.90
ChartMarket Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $171.24M, a decrease of -66.69%. That is a compound annual growth rate of -20.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 171.24M | 19.84% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RxSight | 265.16M |
| Profound Medical | 251.91M |
| InfuSystem Holdings | 243.79M |
| Electromed | 234.25M |
| Neuronetics | 219.45M |
| Quantum-Si incorporated | 167.67M |
| Owlet | 145.52M |
| Inogen | 143.84M |